Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at the 39th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting
Watch Artivion's latest callArtivion (NYSE:AORT) Q2 2026 Earnings Call · Replay · Aug 6Read the transcript of Artivion (NYSE:AORT) Q2 2026 Earnings CallArtivion's next earnings callArtivion (NYSE:AORT) Q3 2026 Earnings Call · Nov 5, 2026 at 4:30 PM ESTRegister
The original release is unavailable here.
Story so far
Earlier from Artivion
- Artivion to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference
- Artivion Reports Second Quarter 2025 Financial Results
- Artivion to Participate in Upcoming Investor Conferences
- Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2025 Financial Results
- Artivion Announces Closing of Transactions to Exchange $99.5 Million in Principal Amount of its 4.250% Convertible Notes Due 2025 for Common Stock
Later from Artivion
- Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2025 Financial Results
- Artivion to Participate in the Stifel 2025 Healthcare Conference
- Artivion Announces Treatment of First Patient with Arcevo LSA in ARTIZEN Pivotal Trial
- Artivion Reports Third Quarter 2025 Financial Results
- Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter 2025 Financial Results
Follow Artivion into a list and get an email when it puts out news.
Follow Artivion